Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 118

1.

[Resection of advanced esophagogastric adenocarcinoma : Extended indications].

Mönig SP, Schiffmann LM.

Chirurg. 2016 May;87(5):398-405. doi: 10.1007/s00104-016-0183-4. German.

PMID:
27138270
2.

Description and analysis of clinical pathways for oesophago-gastric adenocarcinoma, in 10 European countries (the EURECCA upper gastro intestinal group - European Registration of Cancer Care).

Messager M, de Steur W, Boelens PG, Jensen LS, Mariette C, Reynolds JV, Osorio J, Pera M, Johansson J, Kołodziejczyk P, Roviello F, De Manzoni G, Mönig SP, Allum WH; EURECCA Upper GI group (European Registration of Cancer Care).

Eur J Surg Oncol. 2016 Feb 6. pii: S0748-7983(16)00042-1. doi: 10.1016/j.ejso.2016.01.001. [Epub ahead of print]

PMID:
26898839
3.

Glucose transporters 1, 3, 6, and 10 are expressed in gastric cancer and glucose transporter 3 is associated with UICC stage and survival.

Schlößer HA, Drebber U, Urbanski A, Haase S, Baltin C, Berlth F, Neiß S, von Bergwelt-Baildon M, Fetzner UK, Warnecke-Eberz U, Bollschweiler E, Hölscher AH, Mönig SP, Alakus H.

Gastric Cancer. 2015 Dec 7. [Epub ahead of print]

PMID:
26643879
4.

[New aspects of neoadjuvant therapy of malignant tumors of the upper gastrointestinal tract].

Mönig SP, Berlth F, Chon SH.

Zentralbl Chir. 2014 Dec;139(6):569-71. Review. German. No abstract available.

PMID:
25674647
5.

International comparison of the German evidence-based S3-guidelines on the diagnosis and multimodal treatment of early and locally advanced gastric cancer, including adenocarcinoma of the lower esophagus.

Moehler M, Baltin CT, Ebert M, Fischbach W, Gockel I, Grenacher L, Hölscher AH, Lordick F, Malfertheiner P, Messmann H, Meyer HJ, Palmqvist A, Röcken C, Schuhmacher C, Stahl M, Stuschke M, Vieth M, Wittekind C, Wagner D, Mönig SP.

Gastric Cancer. 2015 Jul;18(3):550-63. doi: 10.1007/s10120-014-0403-x. Epub 2014 Sep 7.

PMID:
25192931
6.

[Spectrum of laparoscopic surgery for gastric tumors].

Mönig SP, Chon SH, Weindelmayer J, de Manzoni G, Hölscher AH.

Chirurg. 2014 Aug;85(8):675-82. doi: 10.1007/s00104-014-2753-7. Review. German.

PMID:
25052815
7.

Homozygous GNAS 393C-allele carriers with locally advanced esophageal cancer fail to benefit from platinum-based preoperative chemoradiotherapy.

Alakus H, Bollschweiler E, Hölscher AH, Warnecke-Eberz U, Frazer KA, Harismendy O, Lowy AM, Mönig SP, Eberz PM, Maus M, Drebber U, Siffert W, Metzger R.

Ann Surg Oncol. 2014 Dec;21(13):4375-82. doi: 10.1245/s10434-014-3843-y. Epub 2014 Jul 2.

PMID:
24986238
8.

Validation of 2-mm tissue microarray technology in gastric cancer. Agreement of 2-mm TMAs and full sections for Glut-1 and Hif-1 alpha.

Berlth F, Mönig SP, Schlösser HA, Maus M, Baltin CT, Urbanski A, Drebber U, Bollschweiler E, Hölscher AH, Alakus H.

Anticancer Res. 2014 Jul;34(7):3313-20.

PMID:
24982335
9.

[Quality of life and visceral surgery].

Bollschweiler E, Baltin C, Berlth F, Mönig SP, Hölscher AH.

Chirurg. 2014 Mar;85(3):203-7. doi: 10.1007/s00104-013-2602-0. Review. German.

PMID:
24464336
10.

Extracapsular lymph node spread as a negative prognostic factor of adenocarcinoma of the pancreas and cancer of the papilla of vater.

Prenzel KL, Hölscher AH, Drebber U, Bollschweiler E, Gutschow CA, Stippel DL, Mönig SP.

Pancreas. 2014 Jan;43(1):64-8. doi: 10.1097/MPA.0b013e3182a44a91.

PMID:
24212239
11.

[Experience with an interdisciplinary surgical handbook for medical students].

Wolfgarten E, Mönig SP, Fetzner UK, Schröder W, Bollschweiler E.

Zentralbl Chir. 2012 Apr;137(2):180-6. doi: 10.1055/s-0031-1283810. Epub 2012 Jan 27. German.

PMID:
22287089
12.

Prognostic significance of a new grading system of lymph node morphology after neoadjuvant radiochemotherapy for esophageal cancer.

Bollschweiler E, Hölscher AH, Metzger R, Besch S, Mönig SP, Baldus SE, Drebber U.

Ann Thorac Surg. 2011 Dec;92(6):2020-7. doi: 10.1016/j.athoracsur.2011.06.091.

PMID:
22115212
13.

Neoadjuvant radiochemotherapy in adenocarcinoma of the esophagus: ERCC1 gene polymorphisms for prediction of response and prognosis.

Metzger R, Warnecke-Eberz U, Alakus H, Kütting F, Brabender J, Vallböhmer D, Grimminger PP, Mönig SP, Drebber U, Hölscher AH, Bollschweiler E.

J Gastrointest Surg. 2012 Jan;16(1):26-34; discussion 34. doi: 10.1007/s11605-011-1700-x. Epub 2011 Sep 29.

PMID:
21956434
14.

Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy.

Drebber U, Lay M, Wedemeyer I, Vallböhmer D, Bollschweiler E, Brabender J, Mönig SP, Hölscher AH, Dienes HP, Odenthal M.

Int J Oncol. 2011 Aug;39(2):409-15. doi: 10.3892/ijo.2011.1036. Epub 2011 May 10.

PMID:
21567082
15.

β-catenin and Her2/neu expression in rectal cancer: association with histomorphological response to neoadjuvant therapy and prognosis.

Drebber U, Madeja M, Odenthal M, Wedemeyer I, Mönig SP, Brabender J, Bollschweiler E, Hölscher AH, Schneider PM, Dienes HP, Vallböhmer D.

Int J Colorectal Dis. 2011 Sep;26(9):1127-34. doi: 10.1007/s00384-011-1213-9. Epub 2011 May 3.

PMID:
21538055
16.

Prognostic relevance of demographics and surgical practice for patients with gastric cancer in two centers: in Poland versus Germany.

Jaworski R, Bollschweiler E, Holscher AH, Monig SP, Skokowski J, Zielinski J, Swierblewski M, Kopacz A, Jaskiewicz J.

Gastric Cancer. 2011 Aug;14(3):234-41. doi: 10.1007/s10120-011-0036-2. Epub 2011 Mar 26.

17.

Expression of {beta}-catenin, MUC1 and c-met in diffuse-type gastric carcinomas: correlations with tumour progression and prognosis.

Retterspitz MF, Mönig SP, Schreckenberg S, Schneider PM, Hölscher AH, Dienes HP, Baldus SE.

Anticancer Res. 2010 Nov;30(11):4635-41.

PMID:
21115917
18.

Prognostic relevance of skip metastases in esophageal cancer.

Prenzel KL, Bollschweiler E, Schröder W, Mönig SP, Drebber U, Vallboehmer D, Hölscher AH.

Ann Thorac Surg. 2010 Nov;90(5):1662-7. doi: 10.1016/j.athoracsur.2010.07.008.

PMID:
20971285
19.

Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer.

Alakus H, Afriani N, Warnecke-Eberz U, Bollschweiler E, Fetzner U, Drebber U, Metzger R, Hölscher AH, Mönig SP.

World J Surg. 2010 Dec;34(12):2853-9. doi: 10.1007/s00268-010-0761-4.

PMID:
20730428
20.

Clinical classification systems of adenocarcinoma of the esophagogastric junction.

Mönig SP, Hölscher AH.

Recent Results Cancer Res. 2010;182:19-28. doi: 10.1007/978-3-540-70579-6_2. Review. No abstract available.

PMID:
20676868
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk